New Rx Treats Common Blood Cancer
The US Food and Drug Administration (FDA) has approved a new medication to treat a common type of blood cancer.
Boosting Leukemia Survival
Umbilical cord blood transplants may lead to high survival in patients with leukemia who are at high risk for relapse post-transplant, a new study found.
A New Job for Opdivo
The US Food and Drug Administration (FDA) has approved a new treatment for Hodgkin lymphoma.
Targeted Leukemia Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved the first treatment to specifically target the B-cell lymphoma 2 (BCL-2) protein found in patients with chronic lymphocytic leukemia (CLL).
A New Formulation for Melphalan
The US Food and Drug Administration (FDA) approved a new formula of melphalan under the brand name Evomela to treat patients with multiple myeloma.
New Treatment Offers Hope for Multiple Myeloma
Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.
Cancer Forecast: Leukemia on the Decline in 2016
According to new predictions, 2016 will be a good year for leukemia.
New Leukemia Rx Gets FDA Nod
Doctors may now have another tool in their arsenal for the treatment of chronic lymphocytic leukemia (CLL).
FDA Approves New Leukemia Rx
On January 19, 2016, the U.S. Food and Drug Administration approved ofatumumab (Arzerra Injection, Novartis Pharmaceuticals Corporation) for extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive chronic lymphocytic leukemia (CLL).
A New Treatment Option for Adult Leukemia
Patients may now have an alternative to chemotherapy as their first line of defense against chronic lymphocytic leukemia (CLL).